article thumbnail

Open Source “Wikipedia” for Drug Discovery

Pharma Mirror

Despite untold investment by numerous pharmaceutical companies, FDA-approved drugs that target critical brain functions and conditions like anxiety, depression, and sedation continue to present severe and unpredictable side effects, including suicidal ideation. In 2003 the Human Genome Project provided the first atlas.

article thumbnail

Magazine: Pharma’s green shift with dry powder inhalers

Pharmaceutical Technology

Several pharmaceutical companies are advancing dry powder inhalers (DPIs) for respiratory conditions in an effort to cut down on greenhouse emissions and create a solution that is more eco-friendly than traditional pressurised metered-dose inhalers (pMDIs).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Rashedi Hassan takes over Sales & Marketing management of Telstar’s subsidiary in Bangladesh

Pharma Mirror

The post Rashedi Hassan takes over Sales & Marketing management of Telstar’s subsidiary in Bangladesh appeared first on Pharma Mirror Magazine. Rashedi Hassan holds a Diploma in Engineering from Dhaka Polytechnic Institute. With more than 18.

article thumbnail

Healthware Group appoints Eugene Borukhovich as senior advisor

pharmaphorum

Prior to that, Eugene held pharmacy benefit management, consulting and pharmaceutical company leadership roles, with his most recent role being at Bayer where he led a global digital health team investing, partnering and building ventures.

article thumbnail

Responding to dynamic shifts in value communications

pharmaphorum

OPEN Health’s Beth Lesher and Annemarie Clegg examine what the convergence of medical communications and market access means for pharmaceutical companies. Value in healthcare is a continually changing concept. The post Responding to dynamic shifts in value communications appeared first on.

article thumbnail

A new dawn for clinical trial management

pharmaphorum

Now, the major advance that’s available to pharmaceutical companies is in the amount and range of data they have access to and how it can be applied to the risk-based monitoring and remote monitoring of studies. • Read the full article in pharmaphorum’s Deep Dive digital magazine.

article thumbnail

Enabling new models of care: pursuing pharma’s partnership potential

pharmaphorum

As new approaches to healthcare attainment take hold there will be some degree of uncertainty among pharmaceutical companies about where they fit into the new structures and the holistic care they seek to provide. The post Enabling new models of care: pursuing pharma’s partnership potential appeared first on.